Anti-obesity medication (AOM)
Drugs FDA-approved specifically for chronic weight management, like Wegovy and Zepbound.
AOMs are approved for weight management at BMI ≥30, or ≥27 with a comorbidity. Wegovy and Zepbound are the leading GLP-1 AOMs. US Medicare is legally barred from covering AOMs, a key coverage gap.